Latest Breaking News On - Liandong investment group - Page 1 : vimarsana.com

Biopharmaceutical firm Lynk Pharmaceuticals has bagged 200 million yuan ($28.2 million) in its Series C1 round, according to a release. 

Hong kongHong kong stock exchange onChina lynk pharmaceuticalsDaoxing entrepreneurship investment management centerLynk pharmaceuticalsLiandong investment groupBestzyme bioengineeringChina grand prosperity investmentHangzhou based tailong venture capitalLiandou valleyLilly asiaHong kong listed genscript biotechHong kong stock exchangeGenscript biotechHuatai zijin investmentHong kong listed huatai securities